These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities. Parent MJ; Zimmer ER; Shin M; Kang MS; Fonov VS; Mathieu A; Aliaga A; Kostikov A; Do Carmo S; Dea D; Poirier J; Soucy JP; Gauthier S; Cuello AC; Rosa-Neto P J Neurosci; 2017 Dec; 37(50):12263-12271. PubMed ID: 29097597 [TBL] [Abstract][Full Text] [Related]
5. Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease. Shah TM; Gupta SM; Chatterjee P; Campbell M; Martins RN Mol Psychiatry; 2017 Mar; 22(3):353-363. PubMed ID: 28093567 [TBL] [Abstract][Full Text] [Related]
6. Reversal of LTP-Like Cortical Plasticity in Alzheimer's Disease Patients with Tau-Related Faster Clinical Progression. Koch G; Di Lorenzo F; Del Olmo MF; Bonní S; Ponzo V; Caltagirone C; Bozzali M; Martorana A J Alzheimers Dis; 2016; 50(2):605-16. PubMed ID: 26757193 [TBL] [Abstract][Full Text] [Related]
7. The Brain's Structural Connectome Mediates the Relationship between Regional Neuroimaging Biomarkers in Alzheimer's Disease. Pandya S; Kuceyeski A; Raj A; J Alzheimers Dis; 2017; 55(4):1639-1657. PubMed ID: 27911289 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease. Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777 [TBL] [Abstract][Full Text] [Related]
10. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease. Prvulovic D; Hampel H Clin Chem Lab Med; 2011 Mar; 49(3):367-74. PubMed ID: 21342022 [TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies. Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463 [TBL] [Abstract][Full Text] [Related]
12. Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patients. Bridel C; Hoffmann T; Meyer A; Durieux S; Koel-Simmelink MA; Orth M; Scheltens P; Lues I; Teunissen CE Alzheimers Res Ther; 2017 Jun; 9(1):38. PubMed ID: 28587659 [TBL] [Abstract][Full Text] [Related]
13. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease. Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Buchhave P; Minthon L; Zetterberg H; Wallin AK; Blennow K; Hansson O Arch Gen Psychiatry; 2012 Jan; 69(1):98-106. PubMed ID: 22213792 [TBL] [Abstract][Full Text] [Related]
15. Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting. Weise D; Tiepolt S; Awissus C; Hoffmann KT; Lobsien D; Kaiser T; Barthel H; Sabri O; Gertz HJ J Alzheimers Dis; 2015; 48(2):425-32. PubMed ID: 26402006 [TBL] [Abstract][Full Text] [Related]
16. The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease. Li X; Westman E; Thordardottir S; Ståhlbom AK; Almkvist O; Blennow K; Wahlund LO; Graff C J Alzheimers Dis; 2017; 56(1):327-334. PubMed ID: 27911308 [TBL] [Abstract][Full Text] [Related]
17. Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression. Tok S; Ahnaou A; Drinkenburg W J Alzheimers Dis; 2022; 88(3):809-836. PubMed ID: 34420957 [TBL] [Abstract][Full Text] [Related]
18. A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease. Luo J; Lee SH; VandeVrede L; Qin Z; Ben Aissa M; Larson J; Teich AF; Arancio O; D'Souza Y; Elharram A; Koster K; Tai LM; LaDu MJ; Bennett BM; Thatcher GR Mol Neurodegener; 2016 Apr; 11():35. PubMed ID: 27129593 [TBL] [Abstract][Full Text] [Related]
19. Default mode network connectivity is linked to cognitive functioning and CSF Aβ1-42 levels in Alzheimer's disease. Celebi O; Uzdogan A; Oguz KK; Has AC; Dolgun A; Cakmakli GY; Akbiyik F; Elibol B; Saka E Arch Gerontol Geriatr; 2016; 62():125-32. PubMed ID: 26515126 [TBL] [Abstract][Full Text] [Related]
20. Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults. Pettigrew C; Soldan A; Moghekar A; Wang MC; Gross AL; O'Brien R; Albert M Neuropsychologia; 2015 Nov; 78():63-72. PubMed ID: 26394023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]